Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics

被引:45
作者
Bois, FY [1 ]
机构
[1] INERIS, F-60550 Verneuil En Halatte, France
关键词
Bayesian; human; Markov chain Monte Carlo; mouse; PBPK model; TCE; toxicokinetics; tricholoroethylene; uncertainty analysis; variability;
D O I
10.1289/ehp.00108s2275
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Two physiologically based pharmacokinetic models for trichloroethylene (TCE) in mice and humans were calibrated with new toxicokinetic data sets. Calibration is an important step in model development, essential to a legitimate use of models for research or regulatory purposes. A Bayesian statistical framework was used to combine prior information about the model parameters with the data likelihood to yield posterior parameter distributions for mice, these distributions represent uncertainty. For humans, the use of a population statistical model yielded estimates of both variability and uncertainty in human toxicokinetics of TCE. After adjustment of the models by Markov chain Monte Carlo sampling, the mouse model agreed with a large part of the data. Yet, some data on secondary metabolites were not fit well. The posterior parameter distributions obtained for mice were quite narrow(coefficient of variation [CV] of about 10 or 20%), but these CVs might be underestimated because of the incomplete fit of the model. The data fit, for humans, was better than for mice. Yet, some improvement of the model is needed to correctly describe trichloroethanol concentrations over long time periods. Posterior uncertainties about the population means corresponded to 10-20% CV. In terms of human population variability, volumes and flows varied across subject by approximately 20% CV. The variability was somewhat higher for partition coefficients (between 30 and 40%) and much higher for the metabolic parameters (standard deviations representing about a factor of 2). Finally, the analysis points to differences between human males and females in the toxicokinetics of TCE. The significance of these differences in terms of risk remains to be investigated.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 24 条
[1]   A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice [J].
Abbas, R ;
Fisher, JW .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 147 (01) :15-30
[2]  
Abbas RR, 1996, DRUG METAB DISPOS, V24, P1340
[3]  
Bernardo J.M., 2009, Bayesian Theory, V405
[4]   Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics [J].
Bois, FY .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :307-316
[5]   Population toxicokinetics of benzene [J].
Bois, FY ;
Jackson, ET ;
Pekari, K ;
Smith, MT .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 :1405-1411
[6]   Population toxicokinetics of tetrachloroethylene [J].
Bois, FY ;
Gelman, A ;
Jiang, J ;
Maszle, DR ;
Zeise, L ;
Alexeef, G .
ARCHIVES OF TOXICOLOGY, 1996, 70 (06) :347-355
[7]   Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment [J].
Clewell, HJ ;
Gentry, PR ;
Covington, TR ;
Gearhart, JM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :283-305
[8]  
Davidian M., 1995, NONLINEAR MODELS REP
[9]  
FANNING E, 1997, SOC TOX ANN M CINC O
[10]  
FISHER JW, 1997, COMMUNICATION